Regulations.gov document
Patient-Focused Drug Development: Methods To Identify What Is Important to Patients; Draft…
Notice · FDA-2019-D-4247 · posted Oct 1, 2019
Key facts
| Document ID | FDA-2019-D-4247-0001 |
|---|---|
| Title | Patient-Focused Drug Development: Methods To Identify What Is Important to Patients; Draft Guidance for Industry, Food and Drug Administration Staff, and Other Stakeholders; Availability |
| Document type | Notice |
| Subtype | Notice of Availability |
| Agency | FDA |
| Docket | FDA-2019-D-4247 |
| Posted | Oct 1, 2019 |
| Federal Register citation | 84 FR 52114 |
| FR document number | 2019-21226 |
| Comment period opens | Oct 1, 2019 |
| Comments due | Dec 31, 2019 |
| Effective date | Oct 1, 2019 |
At a glance
- 1–9 Pages
- No Open for comment
- 10–99 Public comments on this docket
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Regulations.gov documents
Regulations.gov holds the rulemaking and other documents federal agencies post for public comment. Only agency documents are published here; public submissions are not.
Source: Regulations.gov (U.S. General Services Administration eRulemaking Program) · Source date: